Late Onset Alzheimer's Disease

Status: Recruiting
Location: See all (12) locations...
Intervention Type: Genetic, Other
Study Type: Observational
SUMMARY

The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Healthy Volunteers: t
View:

• Established diagnosis of definite or probable AD or have a diagnosis of a related neurodegenerative disorder such as Frontotemporal Dementia (FTD) or Lewy Body Dementia (LBD) (will also recruit sporadic FTD and LBD) cases.

• a living sibling with probable or possible AD;

• a third living relative affected with AD (onset age 50 or older) or unaffected (60 or older);

• participants in the proband's generation with an identified companion serving as an informant;

• participants who have capacity to consent or participants lacking capacity to consent with a surrogate/proxy in place to provide consent.

Locations
United States
Washington, D.c.
University of Washington
RECRUITING
Washington D.c.
Florida
University of Miami
RECRUITING
Miami
Illinois
Rush University
RECRUITING
Aurora
Indiana
Indiana University
RECRUITING
Bloomington
NCRAD at Indiana University
RECRUITING
Indianapolis
Minnesota
Mayo Clinic
RECRUITING
Rochester
Missouri
Joanne Norton
RECRUITING
St Louis
North Carolina
North Carolina State University
RECRUITING
Raleigh
New York
Columbia University Irving Medical Center
RECRUITING
New York
Pennsylvania
University of Pittsburgh
RECRUITING
Pittsburgh
Texas
University of Texas Southwestern
RECRUITING
Dallas
Washington
University of Washington
RECRUITING
Seattle
Contact Information
Primary
Dolly Reyes-Dumeyer
dr2290@cumc.columbia.edu
212-305-5953
Backup
Amanda Chan
akc2177@cumc.columbia.edu
917-696-3082
Time Frame
Start Date: 2016-11-15
Estimated Completion Date: 2027-04-30
Participants
Target number of participants: 10000
Treatments
Families with a history of Alzheimer's Disease
Families with two or more family members affected with Alzheimer's Disease
Un-related, non-demented controls
Un-related, non-demented healthy controls over age 55
Individuals with Dementia (Alzheimer's Disease)
Individuals with dementia over the age of 65
Related Therapeutic Areas
Sponsors
Leads: Columbia University
Collaborators: National Institute on Aging (NIA)

This content was sourced from clinicaltrials.gov